In Vitro Evaluation of Drug Susceptibilities of Babesia divergens Isolates

ABSTRACT The susceptibilities of three bovine and two human Babesia divergens isolates to antimicrobial agents were evaluated in vitro by a tritiated hypoxanthine incorporation assay. The MICs at which 50% of isolates are inhibited (MIC50s) for mefloquine (chlorhydrate), chloroquine (sulfate), quinine (chlorhydrate), clindamycin (phosphate), pentamidine (isethionate), phenamidine (isethionate) plus oxomemazine (chlorhydrate), lincomycin (chlorhydrate monohydrate), and imidocarb (dipropionate) were determined. Except for imidocarb, the MIC50s observed for the different isolates were close. Imidocarb and the combination of phenamidine plus oxomemazine exhibited the highest in vitro activity, while antimalarial agents such as mefloquine, choroquine, and quinine were inactive. Other drugs had intermediate activities. The data support further in vitro evaluation of antimicrobial agents active against B. divergens for the improvement of therapeutic strategies.

[1]  J. Gray,et al.  Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens. , 1997, The Journal of parasitology.

[2]  A. Trees,et al.  In vitro responsiveness of Babesia bovis to imidocarb dipropionate and the selection of a drug-adapted line. , 1996, Veterinary parasitology.

[3]  A. Spielman,et al.  CHAPTER 1 – Babesial Infections in Humans and Wildlife , 1993 .

[4]  P. Tan-Ariya,et al.  Development of an in vitro microtest to assess drug susceptibility of Babesia bovis and Babesia bigemina. , 1991, The Journal of parasitology.

[5]  W. O'Sullivan,et al.  Routine screening for potential babesicides using cultures of Babesia bovis. , 1990, International journal for parasitology.

[6]  P. Brasseur,et al.  [2 cases of severe human babesiosis treated successfully]. , 1990, Presse medicale.

[7]  W. M. Lancaster,et al.  Babesiosis in man: Report of a case from scotland with observations on the infecting strain , 1979 .

[8]  E. R. Young,et al.  Further studies on the uptake of tritiated nucleic acid precursors by Babesia spp. of cattle and mice , 1979 .

[9]  R. Rubin,et al.  Neurologic complications following the treatment of human Babesia microti infection with diminazene aceturate. , 1979, The American journal of tropical medicine and hygiene.

[10]  E. R. Young,et al.  Possible in vitro test for screening drugs for activity against Babesia and other blood protozoa , 1977, Nature.

[11]  E. Stebbing.  Britain's National Forests Bedgebury and Cannock Chase , 1952, Nature.